Perspective Therapeutics CATX
NYSE CATX
$3.22 -0.26 (-7.47%)
At close: Aug 20, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Loans - Net (2022)

Perspective Therapeutics (CATX) posted Loans - Net of $6.1 million for Q4 2022.

Perspective Therapeutics (CATX) Loans - Net (2022) Analysis & Trends

Perspective Therapeutics has reported Loans - Net for 1 years, with the latest figure at $6.1 million in Q4 2022.

  • Quarterly Loans - Net changed N/A year-over-year to $6.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $6.1 million (changed N/A YoY) and the FY2022 annual result came in at $6.1 million, changed N/A from the prior year.
  • Loans - Net steadied at $6.1 million in Q4 2022 per CATX's latest filing.
  • Over five years, Loans - Net peaked at $6.1 million in Q4 2022 and troughed at $6.1 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans - Net (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Perspective Therapeutics 389.10 Mn 389.10 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 6.11 Mn
Dec 31, 2022 6.11 Mn